๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

โœ Scribed by Gary Stiefel, Professor Frank M.C. Besag

Book ID
119930896
Publisher
Springer International Publishing AG
Year
2010
Tongue
English
Weight
382 KB
Volume
33
Category
Article
ISSN
0114-5916

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The Art of Drug Synthesis || Approved Tr
The Art of Drug Synthesis || Approved Treatments for Attention Deficit Hyperactivity Disorder: Amphetamine (Adderallยฎ), Methylphenidate (Ritalinยฎ), and Atomoxetine (Straterraยฎ)
โœ Johnson, Douglas S.; Li, Jie Jack ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley & Sons, Inc. ๐ŸŒ English โš– 947 KB

The Role Of Medicinal Chemistry In Drug Discovery / John A. Lowe Iii -- Process Research: How Much? How Soon? / Neal G. Anderson -- Aromatase Inhibitors For Breast Cancer : Exemestane (aromasin), Anastrozole (arimidex), And Letrozole (femara) / Jie Jack Li -- Quinolone Antibiotics : Levofloxacin (le

Pharmacology of methylphenidate, ampheta
Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder
โœ Kennerly S. Patrick; John S. Markowitz ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB ๐Ÿ‘ 2 views

Racemic methylphenidate remains the drug of choice for attention-deยฎcit hyperactivity disorder (ADHD). Methylphenidate appears to produce psychostimulation by inhibiting the presynaptic uptake of impulse-released dopamine. The absolute bioavailability of methylphenidate in humans is quite low and va